Israel’s Ministry of Health has found a possible link between myocarditis (heart inflammation) in males aged 16-30 and the second Pfizer vaccine. In examining the matter, the Ministry has disclosed the findings of its commissioned study stating that among the total 5 million vaccinated people in Israel, there have been 275 detected cases of myocarditis between December 2020 and May 2021. In a statement issued by Pfizer, they said they are aware of the Israeli investigations and that a causal link to its vaccine has not been observed. A U.S. Centers for Disease Control and Prevention (CDC) advisory group stated that data from the Vaccine Safety Datalink (VSD) database has not uncovered any outliers for myocarditis or for pericarditis. Similarly, European Medicines Agency (EMA) stated that there is no cause for concern. After a brief period on hold, Israel has restarted its vaccination program for young adolescents.

Read more here.

More on: